Probiotics for the Treatment of Infantile Colic

A Systematic Review

Anna Schreck Bird, Philip J. Gregory, Mohamed A. Jalloh, Zara Risoldi Cochrane, Darren J. Hein

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

Objective: To evaluate whether clinical data support the safety and efficacy of probiotics for the management of infantile colic. Background: Probiotics have been suggested as a potential strategy for infantile colic, and the specific species that have been studied in healthy infants are considered to be safe. Methodology: A systematic review was conducted to identify randomized controlled trials (RCTs) evaluating the use of probiotic supplementation in infants with colic. RCTs with a primary end point assessing crying or fussing time were selected. A meta-analysis comparing "responders" to "nonresponders" in infants receiving probiotic versus control was conducted. The quality of trials selected was assessed. Results: Five RCTs assessing 2 different strains of the probiotic Lactobacillus reuteri in mostly breastfed infants were identified. Analysis of response rates showed that infants receiving probiotics had a 2.3-fold greater chance of having a 50% or greater decrease in crying/fussing time compared to controls (P =.01). Probiotic supplementation was not associated with any adverse events. Conclusion: Supplementation with the probiotic L. reuteri in breastfed infants appears to be safe and effective for the management of infantile colic. Further research is needed to determine the role of probiotics in infants who are formula-fed.

Original languageEnglish (US)
Pages (from-to)366-374
Number of pages9
JournalJournal of Pharmacy Practice
Volume30
Issue number3
DOIs
StatePublished - Jun 1 2017

Fingerprint

Colic
Probiotics
Lactobacillus reuteri
Crying
Therapeutics
Randomized Controlled Trials
Infant Formula
Meta-Analysis
Safety

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this

Schreck Bird, A., Gregory, P. J., Jalloh, M. A., Risoldi Cochrane, Z., & Hein, D. J. (2017). Probiotics for the Treatment of Infantile Colic: A Systematic Review. Journal of Pharmacy Practice, 30(3), 366-374. https://doi.org/10.1177/0897190016634516

Probiotics for the Treatment of Infantile Colic : A Systematic Review. / Schreck Bird, Anna; Gregory, Philip J.; Jalloh, Mohamed A.; Risoldi Cochrane, Zara; Hein, Darren J.

In: Journal of Pharmacy Practice, Vol. 30, No. 3, 01.06.2017, p. 366-374.

Research output: Contribution to journalReview article

Schreck Bird, A, Gregory, PJ, Jalloh, MA, Risoldi Cochrane, Z & Hein, DJ 2017, 'Probiotics for the Treatment of Infantile Colic: A Systematic Review', Journal of Pharmacy Practice, vol. 30, no. 3, pp. 366-374. https://doi.org/10.1177/0897190016634516
Schreck Bird A, Gregory PJ, Jalloh MA, Risoldi Cochrane Z, Hein DJ. Probiotics for the Treatment of Infantile Colic: A Systematic Review. Journal of Pharmacy Practice. 2017 Jun 1;30(3):366-374. https://doi.org/10.1177/0897190016634516
Schreck Bird, Anna ; Gregory, Philip J. ; Jalloh, Mohamed A. ; Risoldi Cochrane, Zara ; Hein, Darren J. / Probiotics for the Treatment of Infantile Colic : A Systematic Review. In: Journal of Pharmacy Practice. 2017 ; Vol. 30, No. 3. pp. 366-374.
@article{7cb5766d60bb49898a0d50a36390fd1f,
title = "Probiotics for the Treatment of Infantile Colic: A Systematic Review",
abstract = "Objective: To evaluate whether clinical data support the safety and efficacy of probiotics for the management of infantile colic. Background: Probiotics have been suggested as a potential strategy for infantile colic, and the specific species that have been studied in healthy infants are considered to be safe. Methodology: A systematic review was conducted to identify randomized controlled trials (RCTs) evaluating the use of probiotic supplementation in infants with colic. RCTs with a primary end point assessing crying or fussing time were selected. A meta-analysis comparing {"}responders{"} to {"}nonresponders{"} in infants receiving probiotic versus control was conducted. The quality of trials selected was assessed. Results: Five RCTs assessing 2 different strains of the probiotic Lactobacillus reuteri in mostly breastfed infants were identified. Analysis of response rates showed that infants receiving probiotics had a 2.3-fold greater chance of having a 50{\%} or greater decrease in crying/fussing time compared to controls (P =.01). Probiotic supplementation was not associated with any adverse events. Conclusion: Supplementation with the probiotic L. reuteri in breastfed infants appears to be safe and effective for the management of infantile colic. Further research is needed to determine the role of probiotics in infants who are formula-fed.",
author = "{Schreck Bird}, Anna and Gregory, {Philip J.} and Jalloh, {Mohamed A.} and {Risoldi Cochrane}, Zara and Hein, {Darren J.}",
year = "2017",
month = "6",
day = "1",
doi = "10.1177/0897190016634516",
language = "English (US)",
volume = "30",
pages = "366--374",
journal = "Journal of Pharmacy Practice",
issn = "0897-1900",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Probiotics for the Treatment of Infantile Colic

T2 - A Systematic Review

AU - Schreck Bird, Anna

AU - Gregory, Philip J.

AU - Jalloh, Mohamed A.

AU - Risoldi Cochrane, Zara

AU - Hein, Darren J.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Objective: To evaluate whether clinical data support the safety and efficacy of probiotics for the management of infantile colic. Background: Probiotics have been suggested as a potential strategy for infantile colic, and the specific species that have been studied in healthy infants are considered to be safe. Methodology: A systematic review was conducted to identify randomized controlled trials (RCTs) evaluating the use of probiotic supplementation in infants with colic. RCTs with a primary end point assessing crying or fussing time were selected. A meta-analysis comparing "responders" to "nonresponders" in infants receiving probiotic versus control was conducted. The quality of trials selected was assessed. Results: Five RCTs assessing 2 different strains of the probiotic Lactobacillus reuteri in mostly breastfed infants were identified. Analysis of response rates showed that infants receiving probiotics had a 2.3-fold greater chance of having a 50% or greater decrease in crying/fussing time compared to controls (P =.01). Probiotic supplementation was not associated with any adverse events. Conclusion: Supplementation with the probiotic L. reuteri in breastfed infants appears to be safe and effective for the management of infantile colic. Further research is needed to determine the role of probiotics in infants who are formula-fed.

AB - Objective: To evaluate whether clinical data support the safety and efficacy of probiotics for the management of infantile colic. Background: Probiotics have been suggested as a potential strategy for infantile colic, and the specific species that have been studied in healthy infants are considered to be safe. Methodology: A systematic review was conducted to identify randomized controlled trials (RCTs) evaluating the use of probiotic supplementation in infants with colic. RCTs with a primary end point assessing crying or fussing time were selected. A meta-analysis comparing "responders" to "nonresponders" in infants receiving probiotic versus control was conducted. The quality of trials selected was assessed. Results: Five RCTs assessing 2 different strains of the probiotic Lactobacillus reuteri in mostly breastfed infants were identified. Analysis of response rates showed that infants receiving probiotics had a 2.3-fold greater chance of having a 50% or greater decrease in crying/fussing time compared to controls (P =.01). Probiotic supplementation was not associated with any adverse events. Conclusion: Supplementation with the probiotic L. reuteri in breastfed infants appears to be safe and effective for the management of infantile colic. Further research is needed to determine the role of probiotics in infants who are formula-fed.

UR - http://www.scopus.com/inward/record.url?scp=85019555848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019555848&partnerID=8YFLogxK

U2 - 10.1177/0897190016634516

DO - 10.1177/0897190016634516

M3 - Review article

VL - 30

SP - 366

EP - 374

JO - Journal of Pharmacy Practice

JF - Journal of Pharmacy Practice

SN - 0897-1900

IS - 3

ER -